Detalhe da pesquisa
1.
Tyvaso DPI: Drug-device characteristics and patient clinical considerations.
Pulm Pharmacol Ther
; 83: 102266, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37967762
2.
End-of-Life and Palliative Care Issues for Patients Living with Pulmonary Arterial Hypertension: Barriers and Opportunities.
Semin Respir Crit Care Med
; 44(6): 866-876, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37459883
3.
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Ann Hematol
; 100(3): 667-673, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33439304
4.
Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.
Int J Mol Sci
; 21(21)2020 Oct 29.
Artigo
Inglês
| MEDLINE | ID: mdl-33138181
5.
Thyroid Dysfunction in Patients with Pulmonary Artery Hypertension (PAH): The Effect of Therapies Affecting the Prostanoid Pathway.
Lung
; 197(6): 761-768, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31696306
6.
Chronic Thromboembolic Pulmonary Hypertension.
JAMA
; 331(11): 972-973, 2024 03 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38407914
7.
Occurrence and impact of sinusitis in patients with asthma and/or allergic rhinitis.
J Asthma
; 53(6): 635-43, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27064727
8.
Pleural effusions in acute and chronic leukemia and myelodysplastic syndrome.
Curr Opin Pulm Med
; 20(4): 340-6, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24811835
9.
The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?
Am J Respir Crit Care Med
; 197(7): 860-868, 2018 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29256625
10.
Recovery from kidney failure associated with chronic thromboembolic pulmonary hypertension following pulmonary thomboendarterectomy.
Clin Kidney J
; 17(4): sfae047, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38572501
11.
Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial Hypertension.
Chest
; 2024 Mar 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38447640
12.
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.
Lancet Respir Med
; 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38705167
13.
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis.
Chest
; 2024 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38508334
14.
Pulmonary hypertension due to high cardiac output.
Respir Med
; 206: 107034, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36511685
15.
The role of riociguat in combination therapies for pulmonary arterial hypertension.
Respir Med
; 211: 107196, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36889521
16.
Management of pulmonary hypertension associated with valvular heart disease with angiotensin-receptor neprilysin inhibitor.
Pulm Circ
; 13(4): e12303, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37937122
17.
Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification models.
Pulm Circ
; 13(2): e12209, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37020706
18.
The cascade screening in heritable forms of pulmonary arterial hypertension.
Pulm Circ
; 13(3): e12259, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37397234
19.
Impact on Pulmonary Hypertension Hemodynamic Classification Based on the Methodology Used to Measure Pulmonary Artery Wedge Pressure and Cardiac Output.
Ann Am Thorac Soc
; 20(12): 1752-1759, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37561068
20.
Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes.
Chest
; 163(2): 398-406, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36115497